Epidural Nalbuphine Vs Dexmedetomidine For Lower Limb Orthopedic Surgeries
Epidural Nalbuphine Vs Dexmedetomidine For Lower Limb Orthopedic Surgeries
Epidural nalbuphine versus dexmedetomidine as adjuvants to bupivacaine in lower limb orthopedic surgeries for postoperative analgesia: a randomized controlled trial.
BMC Anesthesiol . 2023 Dec 6;23(1):401.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
72 patients with lower limb orthopedic surgeries were randomized to receive epidural bupivacaine with either nalbuphine (n=24), dexmedetomidine (n=24), or saline as a control (n=24). The primary outcome of interest was the duration of postoperative analgesia. Secondary outcomes included the onset of epidural analgesia, sedation scores, patient satisfaction, adverse effects, pain on a Visual Analog...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.